Efficacy of intravitreal dexamethasone implant in persistent diabetic macular edema after primary treatment with intravitreal ranibizumab

Yıldırım, 2005, The effect of intravitreal triamcinolone acetonide on chronic diffuse diabetic macular edema resistant to conventional treatment, Ret-Vit, 13, 261 Roberts, 2006, Blocking ET-1 receptors does not correct subnormal retinal oxygenation response in experimental diabetic retinopathy, Invest Ophthalmol Vis Sci, 47, 3550, 10.1167/iovs.05-1624 Grant, 2004, The role of growth factors in the pathogenesis of diabetic retinopathy, Expert Opin Investig Drugs, 13, 1275, 10.1517/13543784.13.10.1275 Miyamoto, 1999, Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition, Proc Natl Acad Sci U S A, 96, 10836, 10.1073/pnas.96.19.10836 1987, Photocoagulation for diabetic macular edema: early treatment diabetic retinopathy study report no. 4. The early treatment diabetic retinopathy study research group, Int Ophthalmol Clin, 27, 265, 10.1097/00004397-198702740-00006 Aiello, 1997, Vascular endothelial growth factor-induced retinal permeability is mediated protein kinase C in vivo and suppressed by an orally effective b-isoform-selective inhibitor, Diabetes, 46, 1473, 10.2337/diab.46.9.1473 1996 Kwak, 1992, Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection, Arch Ophthalmol, 110, 259, 10.1001/archopht.1992.01080140115038 Maxwell, 1991, Effect of intravitreal dexamethasone on ocular histopathology in a rabbit model of endophthalmitis, Ophthalmology, 98, 1370, 10.1016/S0161-6420(91)32108-0 2014 Chang-Lin, 2011, Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant, Invest Ophthalmol Vis Sci, 52, 80, 10.1167/iovs.10-5285 Waheed, 2013, OCT in the management of diabetic macular edema, Curr Ophthalmol Rep, 1, 128, 10.1007/s40135-013-0019-z Rasta, 2015, Detection of retinal capillary nonperfusion in fundus fluorescein angiogram of diabetic retinopathy, BioImpacts, 5, 183, 10.15171/bi.2015.27 Ryan, 2001, vol II Callanan, 2013, Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema, Ophthalmology, 120, 1843, 10.1016/j.ophtha.2013.02.018 Khan, 2017, Efficacy of the intravitreal sustained-release dexamethasone implant for diabetic macular edema refractory to anti-vascular endothelial growth factor therapy: a meta-analysis and clinical implications, Ophthalmic Surg Lasers Imaging Retina, 48, 160, 10.3928/23258160-20170130-10 Haller, 2010, Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema, Arch Ophthalmol, 128, 289, 10.1001/archophthalmol.2010.21 Boyer, 2014, The three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema, Ophthalmology, 121, 1904, 10.1016/j.ophtha.2014.04.024 Boyer, 2011, Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients, Retina, 31, 915, 10.1097/IAE.0b013e318206d18c Ucgun, 2015, Intravitreal dexamethasone implant for chronic DME resistant to ranibizumab injections Alshahrani, 2016, KKESH International Collaborative retina study group, Retina, 36, 131, 10.1097/IAE.0000000000000616 Yıldırım, 2015, Early results of the implantation of intravitreal dexamethasone in the treatment of macular edema due to diabetic retinopathy and retinal venous obstruction, Firat Üniv Sağ Bil Tıp Derg, 29, 113